tirzepatide pancreatitis gallbladder warning label Comparative safety and side effects of semaglutide and tirzepatide: Implications for clinical decision-making in obesity management Zepbound: Package Insert / Prescribing

BMI is an imperfect measure, but its still one of the tools clinicians and insurers use to determine eligibility

Most of the patents do not expire until 2032 to 2036 in the USA, but in countries like China, India, and Brazil some GLP-1 drugs will come off patent as early as 2026

Early and Long-term consequences of nutritional stunting: from childhood to adulthood

Alternatively, some patients may reduce activity due to gastrointestinal side effects or fatigue, leading to deconditioning and subsequent discomfort when resuming normal activities

PMID: 27379574

Also, foods consumed with more chews and smaller bites can help increase GLP-1 response and curb subsequent food intake in a meal